BD Introduces World’s First Spectral Sorter for Cells with High-Speed ​​Imaging Technology that Sorts Cells Based on Visual Characteristics

The new BD FACSDiscover ™ S8 Cell Sorter incorporates the revolutionary BD CellView image technology рана profiled earlier this year on the cover of the magazine science. It is the first cell sorter to combine advanced spectral flow cytometry with sorting imaging analysis, potentially allowing researchers to obtain more accurate data and sort cells that could not previously be identified.

“This advance in cell sorting fills a long-standing gap in biomedical research by allowing scientists to perform high-parameter experiments while quickly examining and sorting cells with specific, visualized traits of interest,” he said. Son of Maggie Wang, Director of Scientific Operations, Westmead Institute for Medical Research. “For researchers who do spectral flow cytometry, actually seeing the cells you interact with gives you more confidence in the results and allows you to see the cells in a way that has never been possible before and answer questions that may have been unthinkable before.

Sorting cells by spectral flow cytometry is an advanced technique that captures the full spectral signal emitted by sample preparations instead of specific bands, as in traditional flow cytometry, allowing scientists to sort cells using more parameters to better understand human health, disease and treatment.

BD FACSDiscover ™ S8 Cell Sorter combines advanced spectral flow cytometry with the new BD CellView ™ Image technology, which captures images of individual cells passing through the system and sorts them based on detailed microscopic analysis of each image at high sorting speed . This combination allows scientists to get a more accurate picture of cell populations and characteristics that can be visually confirmed in real time, and to interrogate and sort cells that cannot be identified before, all in a simplified experimental workflow. BD FACSDiscover ™ S8 Cell Sorter is the first BD tool to include BD CellView ™ Image Technology.

“By combining the power of high-parameter spectral flow cytometry with this unprecedented picture of a cell and its internal work, we are defining a new standard in cell sorting and placing the power of the cell in the hands of the researcher,” he said. Punet Sarin, world president of BD Biosciences. The BD Cell Sorter BAC FACSDiscover ™ S8 with BD CellView ™ Image Technology is the next chapter in BD’s legacy of innovation and flow cytometry leadership and together with additional tools such as our new spectrally optimized BD Horizon RealYellow and RealBlue reagents, we are excited. to see how the scientific community will use it to make groundbreaking discoveries in less time and with more confidence, and to discover new applications that can help shape the future of health. “

More information about BD FACSDiscover ™ S8 Cell Sorter is available at the CYTO 2022 conference through BD and sales representatives bdbiosciences.com/ s8.

About BD
BD is one of the largest global medical technology companies in the world and it is progress in the world of health ™ by improving medical detection, diagnosis and care. The company supports the heroes of the healthcare front line by developing innovative technologies, services and solutions that help advance both clinical therapy for patients and the clinical process for healthcare providers. BD and its 75,000 employees have a passion and commitment to help improve the safety and effectiveness of the care delivery process for clinicians, enable laboratory scientists to accurately detect disease, and develop the ability of researchers to develop next-generation diagnostics and therapy. BD has a presence in almost every country and partners with organizations around the world to address some of the most challenging global health issues. Working closely with clients, BD can help improve outcomes, reduce costs, increase efficiency, improve safety and expand access to healthcare. For more information on BD, please visit bd.com or contact us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.

Contacts:

Media:

investors:

Troy Kirkpatrick

Francesca de Martino

Vice President, Public Relations

SVP, Head of Investor Relations

858.617.2361

201.847.5743

[email protected]

[email protected]

SOURCE BD (Becton, Dickinson and Company)

Leave a Comment